Literature DB >> 23336245

[A Chinese expert panel consensus on diagnosis and treatment of adult acute lymphoblastic leukemia].

.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23336245     DOI： 10.3760/cma.j.issn.0253-2727.2012.09.028

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN： 0253-2727


× No keyword cloud information.
  11 in total

1.  Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Yinjun Lou; Yafang Ma; Chenyin Li; Sansan Suo; Hongyan Tong; Wenbin Qian; Wenyuan Mai; Haitao Meng; Wenjuan Yu; Liping Mao; Juyin Wei; Weilei Xu; Jie Jin
Journal:  Front Med       Date:  2017-03-27       Impact factor: 4.592

2.  Blastic plasmacytoid dendritic cell neoplasm with leukemic manifestation and ETV6 gene rearrangement: A case report.

Authors:  N A Gao; Xue-Xia Wang; Jian-Rong Sun; Wen-Zheng Yu; Nong-Jian Guo
Journal:  Exp Ther Med       Date:  2015-01-29       Impact factor: 2.447

3.  Targeting High Dynamin-2 (DNM2) Expression by Restoring Ikaros Function in Acute Lymphoblastic Leukemia.

Authors:  Zheng Ge; Yan Gu; Qi Han; Gang Zhao; Min Li; Jianyong Li; Baoan Chen; Tianyu Sun; Sinisa Dovat; Robert Peter Gale; Chunhua Song
Journal:  Sci Rep       Date:  2016-11-25       Impact factor: 4.379

4.  Ikaros regulation of the BCL6/BACH2 axis and its clinical relevance in acute lymphoblastic leukemia.

Authors:  Zheng Ge; Xilian Zhou; Yan Gu; Qi Han; Jianyong Li; Baoan Chen; Qinyu Ge; Elanora Dovat; Jonathon L Payne; Tianyu Sun; Chunhua Song; Sinisa Dovat
Journal:  Oncotarget       Date:  2017-01-31

5.  [Distribution and drug resistance of pathogens of blood stream infection in patients with hematological malignancies after chemotherapy].

Authors:  S Z Chen; K N Lin; M Xiao; X F Luo; Q Li; J H Ren; R Y Huang; M M Chen; Z Z Ally; T Chen; J D Yang; Jianda Hu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-11-14

6.  [The prognostic significance of proportion of blasts in bone marrow on day 14 during induction chemotherapy in patients with adult Ph-negative acute lymphoblastic leukemia].

Authors:  J S Jia; S M Yang; J Wang; H Jiang; T Zhao; L Bao; H X Shi; J Lu; H H Zhu; Y Y Lai; B Jiang; X J Huang; Q Jiang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2016-06-14

7.  [Clinical features and prognosis in CD10(-) pre-B acute lymphoblastic leukemia].

Authors:  X Y Gong; Y Wang; B C Liu; H Wei; C L Zhou; D Lin; K Q Liu; S N Wei; B F Gong; G J Zhang; Y T Liu; X L Zhao; Y Li; R X Gu; S W Qiu; Y C Mi; J X Wang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-01-14

8.  [Expression of Tim-3 in acute leukemia cells and its clinical significance].

Authors:  L J Xu; J G Xu; X L Li; B Liu; Y Yao; H Liu; R X Wang; M Q Zhu; W W Shen; S N Chen; X J Wu; D P Wu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2016-06-14

9.  [Clinical significance of minimal residual disease in patients with Ph-negative precursor B-acute lymphoblastic leukemia].

Authors:  K Q Liu; H Wei; D Lin; Y Wang; C L Zhou; B C Liu; X L Li; Y Zhao; H J Li; C W Wang; Q H Li; B F Li; Y T Gong; X Y Liu; Y C Gong; J X Mi; Jianxiang Wang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2018-09-14

10.  Correlation analysis of long non-coding RNA TUG1 with disease risk, clinical characteristics, treatment response, and survival profiles of adult Ph- Acute lymphoblastic leukemia.

Authors:  Pengyun Zeng; Ye Chai; Chongge You; Lingling Yue; Chongyang Wu; Huiling Chen; Liangliang Li; Jingjing Li; Huan Liu; Yurong Zhang; Tingyong Cao; Yaru Li; Wanli Hu
Journal:  J Clin Lab Anal       Date:  2021-07-12       Impact factor: 2.352
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.